Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential gene expression in classic giant cell tumours of bone: Tenascin C as biological risk factor for local relapses and metastases

1 Jul 2010

Abstract excerpt

Pazzaglia L, Conti A, Chiechi A, Novello C, Magagnoli G, Astolfi A, Pession A, Krenacs T, Alberghini M, Picci P & Benassi M S (2010) Histopathology 57, 59–72 Differential gene expression in classic giant cell tumours of bone: Tenascin C as biological risk factor for local relapses and metastases Aims: To identify candidate prognostic biological markers useful in selecting high‐risk patients with classic primary...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Tumor Diagnosis and Treatments
Share to Musculoskeletal synovial abnormalities and treatments
Share to Oral and Maxillofacial Pathology

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20653781
DOI: 10.1111/j.1365-2559.2010.03597.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential gene expression in classic giant cell tumours of bone: Tenascin C as biological risk factor for local relapses and metastasesPMID 20653781Read ↗

Significance of EGFR/HER2 Expression and PIK3CA Mutations in Giant Cell Tumour of Bone DevelopmentSemantic proximity Read ↗

Genome-Wide Transcriptome Profiling of the Neoplastic Giant Cell Tumor of Bone Stromal Cells by RNA Sequencing.Semantic proximity Read ↗

Expanding the molecular spectrum of tenosynovial giant cell tumorsSemantic proximity Read ↗

MicroRNA expression profiles in metastatic and non-metastatic giant cell tumor of bone.Semantic proximity Read ↗

Giant cell tumor of bone: updated molecular pathogenesis and tumor biology.Semantic proximity Read ↗

Identification of potential diagnostic biomarkers for tenosynovial giant cell tumour by integrating microarray and single-cell RNA sequencing dataSemantic proximity Read ↗

Giant cell tumour of bone in the denosumab era.Semantic proximity Read ↗

Phenotypic and molecular differences between giant-cell tumour of soft tissue and its bone counterpart.Semantic proximity Read ↗

Protein Expression Profiling of Giant Cell Tumors of Bone Treated with Denosumab.Semantic proximity Read ↗

Epidermal growth factor receptor signalling contributes to osteoblastic stromal cell proliferation, osteoclastogenesis and disease progression in giant cell tumour of bone.Semantic proximity Read ↗

Defining a new aggressiveness classification and using NFATc1 localization as a prognostic factor in cherubism.Semantic proximity Read ↗

Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.